FDC Ltd. is a prominent entity in the pharmaceutical industry, primarily engaged in the development, manufacture, and marketing of healthcare products. The company's core product offerings include pharmaceuticals, active pharmaceutical ingredients, and consumer healthcare products targeted towards therapies for lifestyle diseases, vitamins, and nutrition. FDC Ltd. is especially noted for its contributions to the oral rehydration salts (ORS) market, a critical solution in addressing dehydration issues prevalent in various regions. As a player in the healthcare sector, FDC Ltd.'s products are widely available through retail and hospital channels, ensuring accessibility to a broad consumer base. The company plays a vital role in advancing public health initiatives, catering to both domestic and international markets with a strong export presence. Its research and innovation capabilities in drug development are significant, contributing to its reputation and market presence within the pharmaceutical landscape.